Sandra Demaria, Professor at Weill Cornell Medicine, shared a post on LinkedIn:
“What a way to celebrate Cancer Immunotherapy Month!
It was exciting to stand in the balcony with SITC President James Gulley and SITC Biotech Committee Founding Chair Zhen Su who had the honor of ringing the Opening Bell to kick off SITC Biotech Strategic Meeting at the NYSE.
Great discussion and exchange of ideas between leaders in the investment community, academia, biopharma, and other stakeholders to shape the future of cancer immunotherapy treatment.”
2026 SITC Biotech Strategic Meeting at the NYSE
Other articles featuring Sandra Demaria on OncoDaily.